Structural causes of cardiac dysfunction in uremia.

While coronary heart disease is undoubtedly a major cause of cardiac morbidity and mortality in uremia, important noncoronary problems contribute to the common presence of cardiac problems. Based on clinical and experimental studies, we could show: (i) Left ventricular hypertrophy (LVH) can be dissociated, at least in part, from elevation of blood pressure. (ii) In uremia, PTH-dependent intermyocardiocytic fibrosis occurs; it may account, at least in part, for disturbed LV compliance and contribute to the arrhythmogenic potential. (iii) Blood pressure-independent abnormalities of intracardiac arterioles and reduced myocardial capillary supply are observed.

[1]  E. Ritz,et al.  Reduced capillary density in the myocardium of uremic rats--a stereological study. , 1992, Kidney international.

[2]  Identification and characterization of a ouabain-like compound from human plasma. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[3]  K. Tracey,et al.  Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilatation in experimental diabetes. , 1991, The Journal of clinical investigation.

[4]  P. Baumgart,et al.  Blood pressure elevation during the night in chronic renal failure, hemodialysis and after renal transplantation. , 1991, Nephron.

[5]  E. Movilli,et al.  Reversal of left ventricular hypertrophy following recombinant human erythropoietin treatment of anaemic dialysed uraemic patients. , 1991, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[6]  K. Chien,et al.  Endothelin induction of inositol phospholipid hydrolysis, sarcomere assembly, and cardiac gene expression in ventricular myocytes. A paracrine mechanism for myocardial cell hypertrophy. , 1990, The Journal of biological chemistry.

[7]  H. Rüddel,et al.  [Determinants for myocardial hypertrophy in mild essential hypertension. The effect of sodium chloride on left-ventricular hypertrophy]. , 1990, Zeitschrift fur Kardiologie.

[8]  M. Rambausek,et al.  Cardiac changes in uraemia and their possible relationship to cardiovascular instability on dialysis. , 1990, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[9]  H. Matsumoto,et al.  Pathophysiological role of endothelin in acute renal failure. , 1990, Life sciences.

[10]  A. Sniderman,et al.  Regression of left ventricular hypertrophy in dialysis patients following correction of anemia with recombinant human erythropoietin. , 1990, The Canadian journal of cardiology.

[11]  E. Ritz,et al.  Doppler echocardiographic findings in dialysis patients. , 1990, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[12]  M. Safar,et al.  Aortic and large artery compliance in end-stage renal failure. , 1990, Kidney international.

[13]  P. Parfrey,et al.  The clinical course of left ventricular hypertrophy in dialysis patients. , 1990, Nephron.

[14]  E. Ritz,et al.  Diffuse intermyocardiocytic fibrosis in uraemic patients. , 1990, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[15]  A. Mimran,et al.  Influence of sodium intake on left ventricular structure in untreated essential hypertensives. , 1989, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

[16]  M. Safar,et al.  Vascular changes in hemodialysis patients in response to recombinant human erythropoietin. , 1989, Kidney international.

[17]  A. Sniderman,et al.  Impact of left ventricular hypertrophy on survival in end-stage renal disease. , 1989, Kidney international.

[18]  P A Poole-Wilson,et al.  Edema of cardiac origin. Studies of body water and sodium, renal function, hemodynamic indexes, and plasma hormones in untreated congestive cardiac failure. , 1989, Circulation.

[19]  S. Rostand,et al.  Ischemic Heart Disease in Chronic Renal Failure: Management Considerations , 1989 .

[20]  M. Rambausek,et al.  Myocardial interstitial fibrosis in experimental uremia--implications for cardiac compliance. , 1988, Kidney international.

[21]  W. Kramer,et al.  Analysis of left-ventricular changes associated with chronic hemodialysis. A noninvasive follow-up study. , 1988, Nephron.

[22]  H. Dargie,et al.  Ventricular arrhythmias in patients with hypertensive left ventricular hypertrophy. , 1987, The New England journal of medicine.

[23]  D. Levy,et al.  Risk of ventricular arrhythmias in left ventricular hypertrophy: the Framingham Heart Study. , 1987, The American journal of cardiology.

[24]  J. Laragh,et al.  Relation of renin-angiotensin system activity to left ventricular hypertrophy and function in experimental and human hypertension. , 1987, Journal of clinical hypertension.

[25]  M. Rambausek,et al.  Dialysis hypotension--is it related to diastolic left ventricular malfunction? , 1987, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[26]  J. Laragh,et al.  Value of echocardiographic measurement of left ventricular mass in predicting cardiovascular morbid events in hypertensive men. , 1986, Annals of internal medicine.

[27]  J. Whitworth,et al.  EXTRACTION OF PLASMA PRORENIN BY HUMAN HEART , 1986, The Lancet.

[28]  B. Haider,et al.  Arrhythmia susceptibility and myocardial composition in diabetes. Influence of physical conditioning. , 1986, The Journal of clinical investigation.

[29]  S. Rostand,et al.  The epidemiology of coronary artery disease in patients on maintenance hemodialysis: implications for management. , 1986, Contributions to nephrology.

[30]  H. Katus,et al.  Myocardial hypertrophy in rats with renal insufficiency. , 1985, Kidney international.

[31]  A. Wing,et al.  Hypertension and Cardiovascular Risk Factors in Hemodialyzed Diabetic Patients , 1985, Hypertension.

[32]  M. Ledochowski,et al.  Salt sensitivity in humans is linked to enhanced sympathetic responsiveness and to enhanced proximal tubular reabsorption. , 1984, Hypertension.

[33]  E. Ritz,et al.  Atherogenesis in uremia. , 1984, Contributions to nephrology.

[34]  N. Gretz,et al.  Cardiovascular-related causes of death and the fate of patients with renovascular disease. , 1984, Contributions to nephrology.

[35]  W. Kübler,et al.  Reduction of coronary reserve: a mechanism for angina pectoris in patients with arterial hypertension and normal coronary arteries. , 1984, Circulation.

[36]  K. Lynn,et al.  Cardiovascular changes in chronic hemodialysis patients. , 1983, Kidney international.

[37]  C. Whitty,et al.  Letter: Epilepsy and driving. , 1974, Lancet.

[38]  B. Delano,et al.  Myocardial anaerobiosis in anemia in uremic man. , 1972, The American journal of cardiology.

[39]  M. Schatz,et al.  On Sudden Death , 1971, Circulation.